Biosurgery Market is Projected to Reach an Estimate of $27,324.80 Million by 2030, With CAGR of 9.1%: Allied Market Research
The global biosurgery market is experiencing growth due to various factors such as an increase in the prevalence of chronic disease, a surge in the number of surgical procedures, and a strong emphasis on research and development activities, resulting in the launch of novel and innovative products.
Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) — Allied Market Research released a report, titled, “Biosurgery Market by Product Type (Mesh, Anti Adhesive Agents, Hemostatic and Surgical Sealant, Bone Graft Substitutes), by Application (Orthopedic Surgery, Cardiovascular and Thoracic Surgery, General Surgery, Neuro and Spine Surgery), by Source (Synthetic Products and Biologics Products): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the report, the global biosurgery industry is projected to reach $27,324.80 million by 2030, having witnessed a value of $11,425.49 million in 2020, with a compound annual growth rate (CAGR) of 9.1% from 2021 to 2030.
Request Sample of the Report on Biosurgery Market Forecast 2032 – https://www.alliedmarketresearch.com/request-sample/1235
Drivers, restraints, and opportunities:
The global biosurgery market is experiencing growth due to various factors such as a growth in the prevalence of chronic disorder, an increase in the prevalence of surgical procedures, and a robust emphasis on research and development activities, resulting in the launch of new and advanced products. However, the high cost of the products and the need for strict regulations limits the biosurgery market. Moreover, the growth in the number of surgeries, and the rise in the number of sport-related injuries create prolific opportunities for market growth.
The mesh segment to retain its dominance throughout the forecast period-
On the basis of product type, the mesh segment held the major market share in 2020, conserving more than one-third of the global biosurgery market revenue, and is predicted to retain its dominance throughout the forecast period. The growing number of surgical procedures, consisting of cardiovascular and general abdominal surgical treatment, increases the need for anti-adhesives.
Recent Developments in the Biosurgery Market
- In April 2023, Olympus a medical technology company has launched its EndoClot Adhesive (ECA) EndoClot Polysaccharide Hemostatic Spray (PHS), and EndoClot Submucosal Injection Solution (SIS) in the Europe, Africa, and Middle East region.
- In July 2023, Baxter International Inc., one of the global leader in surgical innovation has launched its PERCLOT an absorbable hemostatic powder in the U.S. for the coagulation of mild bleeding. The launch of PERCLOT will help the company to expand its advanced surgery portfolio.
- In December 2021, Becton, Dickinson and Company, a global leader in medical technology has acquired Tissuemed, Ltd. This acquisition will help the company to expand its surgical product portfolio.
- In April 2021, Arora announced the FDA clearance for Myriad Morcells, to optimize the contact with irregular wound beds.
- In February 2020, Integra Lifesciences Holding Corporation has launched its AmnioExcel Plus Placental Allograft Membrane, which is used to support soft tissue repair.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/1235
The neuro and spine surgery segment to maintain its lion’s share throughout the forecast period-
By application, the neuro and spine surgery segment held the major market share in 2020, holding nearly two-fifths of the global biosurgery market revenue, and is projected to maintain its lion’s share throughout the forecast period. On the other hand, the general surgery segment would display the fastest CAGR of 10.2% from 2021 to 2030. This is because of the rise in the number of surgeries, the increase in idle lifestyle, and the growth in the geriatric population.
North America garnered the major share in 2030-
By region, North America held the major market share in 2020, garnering nearly two-fifths of the global biosurgery market revenue, and is likely to dominate the market by 2030. This is due to an increase in chronic disease, a rise in the quantity of surgeries performed, the emergence of key players in the manufacturing of biosurgery products, and growth in research and development (R&D) activities in the healthcare industry.
For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/1235
Industry-Leading Players: –
- Tissue Regenix Group
- Hemostasis LLC
- Medtronic PLC
- Becton, Dickinson and Company
- Sanofi S.A.
- Aroa Biosurgery Limited
- Baxter International Inc.
- Johnson and Johnson
- Integra LifeSciences Holdings Corp.
- B. Braun Melsungen AG
The report offers a comprehensive overview of the leading players in the global biosurgery market. These players have employed various strategies, including the launch of new products, geographical expansion, partnerships, collaborations, and agreements, to expand their market presence and remain dominant in various regions. The report represents the top segments, product portfolio, business performance, and strategic actions of market participants to emphasize the competitive landscapes.
Comprehensive Healthcare Industry Research Studies: –
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.